Totient Bio

An AI-driven, biotechnology company identifying novel tissue-specific antigens and developing matching high-affinity antibody therapeutics.

[Totient Bio @TotientBio]

https://t.co/TqPIZW0IUP

[Milner Therapeutics Institute @TheMilnerInst]

Fantastic news for Milner-affiliated company @TotientBio!

"Together, AbSci & Totient are much more than the sum of our parts, with clear opportunities for synergy of our platforms and technologies," said Deniz Kural, PhD, co-founder and CEO of Totient.

https://t.co/LEzB6m33On

[Johannes Fruehauf🇺🇦 @JFruehauf]

Today, we are celebrating the acquisition of our portfolio company @TotientBio by @abscibio. Another great success started @labcentral with @MissionBioCap as investor.

Great work by @denizkural & team - Congratulations!
https://t.co/IC817ZKNeJ

[Totient Bio @TotientBio]

Welcome, Prof. Simon Tavaré, PhD, FRS FMedSci,
@royalsociety, @acmedsci, @Cancer_dynamics, Bharath Ramsundar, PhD @rbhar90 @deepforestsci, Chris Powell, PhD, FRCPath, FRSB, FBTS, @BritToxSoc @Cambridge_Uni, & Prof. Duncan Jodrell, DM, MSc, FRCP(Edin.), @RCPEdin, @ECMC_UK @CR_UK

[Totient Bio @TotientBio]

We are pleased to announce the formation of our new Scientific Advisory Board.
https://t.co/oDU7jJpBIP

[Totient Bio @TotientBio]

We are pleased to announce the formation of our new Scientific Advisory Board.
https://t.co/oDU7jJpBIP

[Totient Bio @TotientBio]

We're on @joinClubhouse! Tune in on Saturday to hear our cofounders @denizkural and @SietstraJames talk ML and human-derived antibodies with @rbhar90 on @dnatieclub.

[Totient Bio @TotientBio]

Totient's manuscript describing the first large scale study of antigens recognized by fully human intratumoral antibodies is now available on bioRxiv.
https://t.co/2B4ZyDdzz6

[Integral Molecular @IntegralMoleclr]

Learn more about our exciting new partnership with @TotientBio!
https://t.co/x2j1mkunrG

[Totient Bio @TotientBio]

We are pleased to announce that Totient has partnered @IntegralMoleclr to screen our antibodies against one of the world's largest (6,000!) collections of native human membrane proteins.

https://t.co/a3BiLi1ysS

[Totient Bio @TotientBio]

Thanks @JFruehauf @labcentral @MissionBioCap! Your early support of Totient's discovery platform and vision was a key enabler of today's milestone.

[Johannes Fruehauf🇺🇦 @JFruehauf]

Great coverage today for @labcentral #AI company @totientbio & @Ginkgo for their fascinating work discovering human #SARSCoV2 neutralizing antibodies. This could be a fast-track to #COVID19 therapy !

cc @denizkural @jrkelly @MissionBioCap @endpts

https://t.co/KVe48fueQr

[Totient Bio @TotientBio]

Thank you @MNakada! So grateful for your support over the years!

[Marian T. Nakada @MNakada]

Promising Cambridge #startup @Totientbio is out of #stealth mode with antibody therapy for #COVID

[Totient Bio @TotientBio]

Check out our feature in @endpts! We are thrilled to publicly share our novel approach to identifying COVID-19 neutralizing antibodies from infection sites in the lung. Thanks to @Ginkgo @jrkelly @ECratsenburg @AnnaMarieWagner @AveraHealth
https://t.co/pfocO9sDnx

[Totient Bio @TotientBio]

Totient Partners with @Ginkgo Bioworks to Apply Unique Discovery Platform to COVID-19 Antibody Efforts
https://t.co/GSs1vldX5G

[Varro Analytics 🇺🇸 @Varro_Analytics]

Time for @Ginkgo's mammalian foundry to shine ?

“We’re hoping we become a household name"
-Narendra Maheshri, head of mammalian biology

"We're sampling antibodies directly involved in tissues under #COVID19 attack"
-@denizkural, @TotientBio

$BLI
#synbio
https://t.co/FmhPCAvPv4

[Totient Bio @TotientBio]

We are excited to emerge from stealth and share what our team of 19 immunologists, cancer biologists, medical doctors, computational chemists, and machine learning and bioinformatics engineers have been working on! https://t.co/ulXadqUfst